Unknown

Dataset Information

0

Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction.


ABSTRACT: In a recent study, we demonstrated the potential of a cell-penetrating peptide (CPP) penetratin to deliver the peptide drug insulin to the brain via nasal administration, and its pharmacological effect on the mild cognitive dysfunction in senescence-accelerated mouse (SAMP8). However, the therapeutic potential of intranasal insulin administration was attenuated when applied to the aged SAMP8 with severe cognitive dysfunction. The present study, therefore, aimed to overcome the difficulty in treating severe cognitive dysfunction using insulin by investigating potential alternatives, glucagon-like peptide-1 (GLP-1) receptor agonists such as exendin-4. Examination using normal ddY mice demonstrated that the distribution of exendin-4 throughout the brain was dramatically increased by intranasal coadministration with the L-form of penetratin. The activation of hippocampal insulin signaling after the simultaneous nose-to-brain delivery of exendin-4 and an adequate level of insulin were confirmed by analyzing the phosphorylation of Akt. Furthermore, spatial learning ability, evaluated in the Morris water maze test after daily administration of exendin-4 with L-penetratin and supplemental insulin for 4 weeks, suggested therapeutic efficacy against severe cognitive dysfunction. The present study suggests that nose-to-brain delivery of exendin-4 with supplemental insulin, mediated by CPP coadministration, shows promise for the treatment of progressive cognitive dysfunction in SAMP8.

SUBMITTER: Kamei N 

PROVIDER: S-EPMC6281676 | biostudies-other | 2018 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction.

Kamei Noriyasu N   Okada Nobuyuki N   Ikeda Takamasa T   Choi Hayoung H   Fujiwara Yui Y   Okumura Haruka H   Takeda-Morishita Mariko M  

Scientific reports 20181205 1


In a recent study, we demonstrated the potential of a cell-penetrating peptide (CPP) penetratin to deliver the peptide drug insulin to the brain via nasal administration, and its pharmacological effect on the mild cognitive dysfunction in senescence-accelerated mouse (SAMP8). However, the therapeutic potential of intranasal insulin administration was attenuated when applied to the aged SAMP8 with severe cognitive dysfunction. The present study, therefore, aimed to overcome the difficulty in trea  ...[more]

Similar Datasets

| S-EPMC3615965 | biostudies-literature
| S-EPMC2881692 | biostudies-literature
| S-EPMC3196123 | biostudies-literature
| S-EPMC8400200 | biostudies-literature
| S-EPMC8699060 | biostudies-literature
| S-EPMC2796831 | biostudies-literature
| S-EPMC5245960 | biostudies-other
| S-EPMC9666501 | biostudies-literature
| S-EPMC5045823 | biostudies-literature
| S-EPMC3739727 | biostudies-literature